Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. S-1MEF Other S-1MEF
  2. 3 Insider Initial Statement of Ownership
  3. 8-A12B Other Registration of Securities
  4. FWP Offering Free Writing Prospectus
  5. S-1/A Offering Registration Statement
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. S-1/A Offering Registration Statement
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. S-1/A Offering Registration Statement
  14. S-1/A Offering Registration Statement
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. S-1 Offering Registration Statement
  17. UPLOAD Other SEC-generated Letter
  18. DRS/A Other Draft Registration Statement
  19. UPLOAD Other SEC-generated Letter
  20. DRS/A Other Draft Registration Statement

Page 36 of 37 · 725 filings